1. Home
  2. OPLN vs ARQT Comparison

OPLN vs ARQT Comparison

Compare OPLN & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OPENLANE Inc.

OPLN

OPENLANE Inc.

N/A

Current Price

$41.01

Market Cap

3.9B

Sector

N/A

ML Signal

N/A

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$27.58

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPLN
ARQT
Founded
2006
2016
Country
United States
United States
Employees
4800
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.5B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
OPLN
ARQT
Price
$41.01
$27.58
Analyst Decision
Buy
Strong Buy
Analyst Count
4
6
Target Price
$32.00
$34.00
AVG Volume (30 Days)
860.5K
1.7M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
88.79
EPS
N/A
N/A
Revenue
N/A
$376,072,000.00
Revenue This Year
$9.43
$34.85
Revenue Next Year
$6.80
$29.39
P/E Ratio
N/A
N/A
Revenue Growth
N/A
91.34
52 Week Low
$25.81
$13.70
52 Week High
$42.47
$31.77

Technical Indicators

Market Signals
Indicator
OPLN
ARQT
Relative Strength Index (RSI) 59.06 61.20
Support Level $36.17 $27.63
Resistance Level $42.47 $27.79
Average True Range (ATR) 1.31 1.24
MACD -0.17 -0.08
Stochastic Oscillator 54.66 54.25

Price Performance

Historical Comparison
OPLN
ARQT

About OPLN OPENLANE Inc.

Openlane Inc provides a digital marketplace for used vehicles, connecting sellers and buyers in North America and Europe for fast and transparent transactions. Its services include financing, repossessions, repairs, transportation, warranty, and inventory management. The company operates used-vehicle auctions and has two main segments: Marketplace and Finance, with majority revenue coming from the Marketplace segment, which to used vehicle remarketing, including marketplace services, remarketing, or make ready services and all are interrelated, synergistic elements along the auto remarketing chain. The Finance segment, through AFC engaged in business of providing short-term, inventory-secured financing to independent vehicle dealers.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

Share on Social Networks: